Brescia, Italy-based Antares Vision (antaresvision.us) and ALP.I SPAC have reached an agreement to merge.The goal is to provide support for and accelerate the growth path undertaken by Antares Vision. 

Antares Vision is a leader in the pharmaceutical sector, in the design, realization and implementation of traceability solutions — hardware and software — with more than 2,000 installations in product lines in over 200 pharmaceutical facilities worldwide. 

Track & Trace, Visual Inspection and Smart Data Management are the main business lines on which Antares Vision’s fully scalable technology product offering is based. The company also offers a portfolio of maintenance and post-sales assistance services.

The pharmaceutical industry has an important regulatory component linked to drug anti-counterfeiting measures, meaning that such systems have been adopted earlier. However, Antares Vision believes that these tracking solutions will soon be extended to other non-pharmaceutical industrial sectors — such as food, beverages, biomedical devices, OTC drugs and cosmetics — which are equally demanding and sensitive to quality control and supply chain transparency issues.